Tipsheet
What matters at India’s listed companies
Earnings · Medical Equipment · Micro cap

Amkay Products revenue grows 9.5% but profits slip on rising costs

The medical device manufacturer reported FY26 revenue of ₹42.03 crore, yet net profit fell to ₹2.31 crore from ₹3.34 crore a year earlier.


Mkt cap₹52.8 cr
P/E15.82×
ROE13.87%
Debt / eq.0.11
₹2.31 cr Net profit for the fiscal year ended March 31, 2026.

What's new

  • Annual revenue rose 9.5% to ₹42.03 crore.
  • Net profit dropped to ₹2.31 crore from ₹3.34 crore in the prior year.
  • The board re-appointed the company's internal auditors for the next fiscal year.

Why this matters

Revenue growth is failing to translate into bottom-line gains for this nano-cap manufacturer. The contraction in profit suggests that rising operational costs are eating into margins, a trend that warrants scrutiny for a company of this size.

What we're watching

  • Whether the company can stabilize its margins in the coming quarters.
  • Details on the specific operational costs driving the profit decline.
  • Future updates on the company's cost-management strategy.

The full read

Amkay Products reported ₹42.03 crore in revenue for the fiscal year ended March 31, 2026, marking a 9.5% increase over the previous year.

Profitability moved in the opposite direction. Net profit dropped to ₹2.31 crore from ₹3.34 crore in the prior fiscal year, as rising operational costs outpaced the company's ability to scale.

With a market capitalization of just ₹53 crore, the company faces a clear challenge in maintaining margins while it attempts to grow its revenue base. The next test is whether management can control these rising costs in the current fiscal year.

Questions answered

How did Amkay Products perform in FY26?
The company grew its revenue by 9.5% to reach ₹42.03 crore. However, its net profit declined to ₹2.31 crore from the ₹3.34 crore reported in the previous fiscal year.
What is the primary reason for the profit decline?
The results suggest that rising operational costs are the main factor behind the lower profitability. The company has not provided a detailed breakdown of these expenses.
Did the board announce any governance changes?
No. The board confirmed the re-appointment of the existing internal auditors for the upcoming fiscal year.
What is the scale of Amkay Products?
Amkay is a nano-cap medical device manufacturer with a market capitalization of ₹53 crore.
Mentioned: Amkay Products · FY26
Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.